Augmedix, Inc. provided revenue guidance for the year 2024. For the year, the company expects to generate revenue of approximately $52 million to $55 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.82 USD | -3.53% | -17.96% | -85.98% |
06-04 | Augmedix, Inc. Reiterates Earnings Guidance for the Second Quarter and Full Year of 2024 | CI |
05-29 | Augmedix Appoints Alex Stinard as Chief Clinical AI Officer | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-85.98% | 41.62M | |
+13.19% | 69.59B | |
+6.55% | 17.32B | |
+23.83% | 14.04B | |
+9.93% | 13.39B | |
+16.16% | 10.16B | |
-21.51% | 6.65B | |
-4.21% | 5.98B | |
+2.69% | 5.28B | |
+8.06% | 4.85B |
- Stock Market
- Equities
- AUGX Stock
- News Augmedix, Inc.
- Augmedix, Inc. Provides Revenue Guidance for the Year 2024